Global Calcium Channel Blocker Market Size study & Forecast, by Drug Class (Dihydropyridine, Benzothizepine, Phenylalkylamine), Distribution Channel (Hospitals, Retail Pharmacies, and Others) and Regional Analysis, 2022-2029

Description

List of Tables

Global Calcium Channel Blocker Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than 5.1% over the forecast period 2022-2029. Calcium channel blockers are a class of drugs that lower blood pressure by stopping calcium from entering heart and artery cells. Stronger cardiac muscle contractions are caused by calcium. Calcium channel blockers facilitate this by allowing blood arteries to relax, which increases the flow of blood and ensures that the heart receives the necessary amount of oxygen. The market growth is driven by significant factors such as increase in cardiovascular diseases and rising demand for Oral Drugs.

Heart failure is a chronic, incapacitating cardio-renal-metabolic condition that affects at least 60 million people globally, according to a news release published by Boehringer Ingelheim GmbH in August 2021. There is an urgent need for novel treatment alternatives as heart failure prevalence rises. Additionally, the market is anticipated to rise due to rising hypertension rates, an increase in hospitals, and government efforts. For instance, the American Hospital Association estimates that there were 6,090 hospitals in the United States as of 2021. According to data updated by the World Health Organization (WHO) in August 2021, more than 700 million people worldwide have untreated hypertension, and as of that year, 1.28 billion people worldwide had hypertension, a sharp increase over the previous few decades. However, lack of skilled professionals' stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Calcium Channel Blocker Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is expected to hold a major market share owing to increasing prevalence rate of cardiovascular diseases. However, Asia Pacific is expected to be the fastest growing region due to large number of generic manufacturer and developing healthcare facilities.

Major market players included in this report are:

Bausch Health Company Inc.

Abbvie Inc

Lupin Pharmaceuticals, Inc

Arbor Pharmaceuticals LLC

Alvogen

Exela Pharma Sciences, LLC

Covis Pharma BV

Novartis AG

GlaxoSmithKline LLC

Pfizer Inc

Recent Developments in the Market:

The FDA approved Norliqva (amlodipine) oral solution in February 2022 to treatment hypertension in adults and children aged 6 and older, as well as to prevent coronary artery disease.
The American Food and Drug Administration (FDA) received provisional permission in May 2022 for Zydus Worldwide DMCC's subsidiary to commercialize Selexipag tablets for the treatment of pulmonary arterial hypertension (PAH) in adults.

Global Calcium Channel Blocker Market Report Scope:

Historical Data: 2019-2020-2021

Base Year for Estimation: 2021

Forecast period: 2022-2029

Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends

Segments Covered: Drug Class, Distribution Channel, Region

Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World

Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Dihydropyridine

Benzothizepine

Phenylalkylamine

By Distribution Channel:

Hospitals

Retail Pharmacies

Others

By Region:

North America

U.S.

Canada

Europe

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
- 1.2.1. Calcium Channel Blocker Market, by Region, 2019-2029 (USD Billion)
- 1.2.2. Calcium Channel Blocker Market, by Drug Class, 2019-2029 (USD Billion)
- 1.2.3. Calcium Channel Blocker Market, by Distribution Channel, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Calcium Channel Blocker Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Calcium Channel Blocker Market Dynamics

3.1. Calcium Channel Blocker Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
  - 3.1.1.1. Increase in Cardiovascular Diseases
  - 3.1.1.2. Rising demand for oral drugs
- 3.1.2. Market Challenges
  - 3.1.2.1. Lack of skilled professionals
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increasing demand for retail pharmacies
  - 3.1.3.2. Increased clinical studies and government initiatives

Chapter 4. Global Calcium Channel Blocker Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Calcium Channel Blocker Market, by Drug Class

6.1. Market Snapshot
6.2. Global Calcium Channel Blocker Market by Drug Class, Performance - Potential Analysis
6.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Drug Class 2019-2029 (USD Billion)
6.4. Calcium Channel Blocker Market, Sub Segment Analysis
- 6.4.1. Dihydropyridine
- 6.4.2. Benzothizepine
- 6.4.3. Phenylalkylamine

Chapter 7. Global Calcium Channel Blocker Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Calcium Channel Blocker Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Calcium Channel Blocker Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Billion)
7.4. Calcium Channel Blocker Market, Sub Segment Analysis
- 7.4.1. Hospitals
- 7.4.2. Retail Pharmacies
- 7.4.3. Others

Chapter 8. Global Calcium Channel Blocker Market, Regional Analysis

8.1. Calcium Channel Blocker Market, Regional Market Snapshot
8.2. North America Calcium Channel Blocker Market
- 8.2.1. U.S. Calcium Channel Blocker Market
  - 8.2.1.1. Drug Class breakdown estimates & forecasts, 2019-2029
  - 8.2.1.2. Distribution Channel breakdown estimates & forecasts, 2019-2029
- 8.2.2. Canada Calcium Channel Blocker Market
8.3. Europe Calcium Channel Blocker Market Snapshot
- 8.3.1. U.K. Calcium Channel Blocker Market
- 8.3.2. Germany Calcium Channel Blocker Market
- 8.3.3. France Calcium Channel Blocker Market
- 8.3.4. Spain Calcium Channel Blocker Market
- 8.3.5. Italy Calcium Channel Blocker Market
- 8.3.6. Rest of Europe Calcium Channel Blocker Market
8.4. Asia-Pacific Calcium Channel Blocker Market Snapshot
- 8.4.1. China Calcium Channel Blocker Market
- 8.4.2. India Calcium Channel Blocker Market
- 8.4.3. Japan Calcium Channel Blocker Market
- 8.4.4. Australia Calcium Channel Blocker Market
- 8.4.5. South Korea Calcium Channel Blocker Market
- 8.4.6. Rest of Asia Pacific Calcium Channel Blocker Market
8.5. Latin America Calcium Channel Blocker Market Snapshot
- 8.5.1. Brazil Calcium Channel Blocker Market
- 8.5.2. Mexico Calcium Channel Blocker Market
8.6. Rest of The World Calcium Channel Blocker Market

Chapter 9. Competitive Intelligence

9.1. Top Market Strategies
9.2. Company Profiles
- 9.2.1. Bausch Health Company Inc.
  - 9.2.1.1. Key Information
  - 9.2.1.2. Overview
  - 9.2.1.3. Financial (Subject to Data Availability)
  - 9.2.1.4. Product Summary
  - 9.2.1.5. Recent Developments
- 9.2.2. Abbvie Inc
- 9.2.3. Lupin Pharmaceuticals, Inc
- 9.2.4. Arbor Pharmaceuticals LLC
- 9.2.5. Alvogen
- 9.2.6. Exela Pharma Sciences, LLC
- 9.2.7. Covis Pharma BV
- 9.2.8. Novartis AG
- 9.2.9. GlaxoSmithKline LLC
- 9.2.10. Pfizer Inc

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Calcium Channel Blocker Market, report scope
TABLE 2. Global Calcium Channel Blocker Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Calcium Channel Blocker Market estimates & forecasts by Drug Class 2019-2029 (USD Billion)
TABLE 4. Global Calcium Channel Blocker Market estimates & forecasts by Distribution Channel 2019-2029 (USD Billion)
TABLE 5. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Calcium Channel Blocker Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Calcium Channel Blocker Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Calcium Channel Blocker Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Calcium Channel Blocker Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Calcium Channel Blocker Market
TABLE 70. List of primary sources, used in the study of global Calcium Channel Blocker Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

FIG 1. Global Calcium Channel Blocker Market, research methodology
FIG 2. Global Calcium Channel Blocker Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Calcium Channel Blocker Market, key trends 2021
FIG 5. Global Calcium Channel Blocker Market, growth prospects 2022-2029
FIG 6. Global Calcium Channel Blocker Market, porters 5 force model
FIG 7. Global Calcium Channel Blocker Market, pest analysis
FIG 8. Global Calcium Channel Blocker Market, value chain analysis
FIG 9. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Calcium Channel Blocker Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Calcium Channel Blocker Market, regional snapshot 2019 & 2029
FIG 15. North America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
FIG 16. Europe Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Calcium Channel Blocker Market 2019 & 2029 (USD Billion)
FIG 19. Global Calcium Channel Blocker Market, company Market share analysis (2021)